Literature DB >> 36053354

Factors related to ultrafiltration volume with icodextrin dialysate use in children.

Naoaki Mikami1, Riku Hamada2,3, Ryoko Harada1, Yuko Hamasaki1,4, Kenji Ishikura1,5, Masataka Honda1,6, Hiroshi Hataya1,6,7.   

Abstract

BACKGROUND: Icodextrin has a lower absorption rate, and icodextrin peritoneal dialysate contributes to more water removal than glucose dialysate in patients with high peritoneal permeability. There are limited data on icodextrin dialysate use in children.
METHODS: This study included all pediatric patients who received peritoneal equilibration tests and peritoneal dialysis with icodextrin dialysate at the study center. The factors related to ultrafiltration volume with icodextrin dialysate with long dwell time were statistically analyzed. Then the ultrafiltration volume with icodextrin and medium-concentration glucose dialysate was compared in individual cycles in the same patients.
RESULTS: Thirty-six samples were included in the icodextrin group, and nine samples were used to compare the ultrafiltration volume with icodextrin and glucose dialysate. Dwell time, D/P-creatinine, D/D0-glucose, age, height, and weight correlated significantly with the ultrafiltration volume of icodextrin dialysate (p < 0.05). A dwell volume equal to or more than 550 mL/m2 was associated with a significantly higher ultrafiltration volume than a lower dwell volume (p = 0.039). Multiple regression analysis revealed that dwell time (p = 0.038) and height (p < 0.01) correlated with ultrafiltration volume significantly. In addition, the ultrafiltration volume was superior (p < 0.01), and dwell time was longer (p = 0.02), with icodextrin dialysate than with medium-concentration glucose dialysate.
CONCLUSIONS: The ultrafiltration volume with icodextrin dialysate decreases in patients with small stature. Providing sufficient dwell time and volume is important for maximal water removal even in children. Ultrafiltration volume is superior with icodextrin than medium-concentration glucose dialysate for long dwell times. A higher resolution version of the Graphical abstract is available as Supplementary information.
© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.

Entities:  

Keywords:  Children; Icodextrin; Kidney replacement therapy; Peritoneal dialysis

Year:  2022        PMID: 36053354     DOI: 10.1007/s00467-022-05720-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  12 in total

1.  Clinical experience with icodextrin in children: ultrafiltration profiles and metabolism.

Authors:  A W de Boer; C H Schröder; R van Vliet; J L Willems; L A Monnens
Journal:  Pediatr Nephrol       Date:  2000-11       Impact factor: 3.714

2.  Osmotic agents and ultrafiltration in peritoneal dialysis.

Authors:  Z J Twardowski; R Khanna; K D Nolph
Journal:  Nephron       Date:  1986       Impact factor: 2.847

3.  The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients.

Authors:  M M Pannekeet; A L Imholz; D G Struijk; G C Koomen; M J Langedijk; N Schouten; R de Waart; J Hiralall; R T Krediet
Journal:  Kidney Int       Date:  1995-09       Impact factor: 10.612

4.  The peritoneal equilibration test in children.

Authors:  D F Geary; E A Harvey; J H MacMillan; Y Goodman; M Scott; J W Balfe
Journal:  Kidney Int       Date:  1992-07       Impact factor: 10.612

5.  Impact of fill volume on ultrafiltration with icodextrin in children on chronic peritoneal dialysis.

Authors:  Sharon Rousso; Tonny M Banh; Susan Ackerman; Elizabeth Piva; Christoph Licht; Elizabeth A Harvey
Journal:  Pediatr Nephrol       Date:  2016-05-13       Impact factor: 3.714

6.  Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance.

Authors:  N Posthuma; P M ter Wee; H A Verbrugh; P L Oe; E Peers; J Sayers; A J Donker
Journal:  Nephrol Dial Transplant       Date:  1997-03       Impact factor: 5.992

7.  A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.

Authors:  C D Mistry; R Gokal; E Peers
Journal:  Kidney Int       Date:  1994-08       Impact factor: 10.612

Review 8.  Should sodium removal in peritoneal dialysis be estimated from the ultrafiltration volume?

Authors:  Michel Fischbach; Ariane Zaloszyc; Betti Schaefer; Claus Peter Schmitt
Journal:  Pediatr Nephrol       Date:  2016-04-18       Impact factor: 3.714

9.  NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.

Authors:  Ramón Paniagua; María-de-Jesús Ventura; Marcela Avila-Díaz; Héctor Hinojosa-Heredia; Antonio Méndez-Durán; Alfonso Cueto-Manzano; Alejandra Cisneros; Alfonso Ramos; Clara Madonia-Juseino; Francisco Belio-Caro; Fernando García-Contreras; Pedro Trinidad-Ramos; Rosario Vázquez; Begoña Ilabaca; Guadalupe Alcántara; Dante Amato
Journal:  Nephrol Dial Transplant       Date:  2009-08-12       Impact factor: 5.992

10.  Long Peritoneal Dialysis Dwells With Icodextrin: Kinetics of Transperitoneal Fluid and Polyglucose Transport.

Authors:  Anna Olszowska; Jacek Waniewski; Joanna Stachowska-Pietka; Elvia Garcia-Lopez; Bengt Lindholm; Zofia Wańkowicz
Journal:  Front Physiol       Date:  2019-10-29       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.